ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1419	National Cancer Institute	Html	en	Lung Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for lung cancer.	lung cancer screening 0.756773 initial screening test 0.3898 LDCT lung cancer 0.431859 sputum cytology 0.442562 U.K. Lung Cancer 0.42482 negative screening test 0.411746 lung cancer 0.9987 lung cancer mortality. 0.430481 current smokers 0.386204 intense screening regimen 0.386147 Early Lung Cancer 0.463536 chest imaging 0.420806 positive screening result 0.397336 lung abnormalities 0.397732 excess lung cancer 0.416122 Lung Screening Trial 0.503515 group 0.383474 intervention arm 0.382743 lung cancer problem 0.42431 positive screening test 0.414453 screening phase 0.386735 lung cancers 0.45033 major lung abnormality 0.402566 LDCT screening 0.417092 lung cancer cases 0.428353	randomized Danish Lung 0.39566 positive screening tests 0.398319 chest radiographic screening 0.412733 cancer screening program 0.414425 lung component 0.385589 Danish Lung Cancer 0.447818 Screening pilot trial 0.393797 Lung Cancer Action 0.443317 participants 0.389736 National Lung Screening 0.500437 Lung Cancer Detection 0.423833 CT screening program 0.391863 Randomized Lung Cancer 0.430455 small lung cancers 0.401362 screening exams 0.383361 lung cancer. 0.390552 lung cancer deaths 0.457228 PLCO Cancer Screening 0.408534 lung cancer death 0.470333 Mayo Lung Project 0.426524 screening test 0.418941 lung cancer mortality 0.632713 lung cancer incidence 0.423847 Cancer Screening Trial 0.513616	CLICK HERE
1542	National Cancer Institute	Html	en	Uterine Sarcoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of uterine sarcomas.	cancer treatment 0.326283 cancer spreads 0.27392 body 0.30595 PDQ cancer information 0.340432 clinical trial search 0.337812 uterus 0.36876 metastatic uterine sarcoma 0.28805 clinical trials 0.632813 cancer information summary 0.313263 clinical trial 0.463679 Transvaginal ultrasound exam 0.270971 patients 0.291529 Recurrent uterine sarcoma 0.312941 total abdominal hysterectomy 0.33979 treatment clinical trial 0.271689 NCI PDQ cancer 0.280198 Treatment Option Overview 0.316082 radiation therapy 0.397408 Treatment Editorial Board 0.278942 General information 0.276617 general cancer information 0.27165 treatment 0.476479 uterine sarcoma cells 0.294562 NCI-supported cancer 0.289424 cancer cells 0.449324	Cancer Information Service 0.272134 Uterine Sarcoma Treatment 0.298886 Option Overview section 0.306678 Uterine Cancer Home 0.286123 treatment clinical trials 0.296817 National Cancer Institute 0.35406 new treatment 0.296864 uterine sarcoma 0.941913 Uterine Sarcoma section 0.285791 diagnose uterine sarcoma 0.300059 PDQ summary 0.281429 uterine sarcoma spreads 0.28676 cancer clinical trials 0.348942 stage 0.302932 Endometrial Cancer Treatment 0.295433 high-energy sound waves 0.275392 fallopian tubes 0.310914 Tissue Sarcoma Treatment 0.291575 treatment options 0.275101 cancer information summaries 0.270428 comprehensive cancer information 0.27068 cancer 0.782046 information 0.353338 standard treatment 0.299992	CLICK HERE
1544	National Cancer Institute	Html	en	Adult Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.	adult aml 0.716289 red blood cells 0.594071 cancer treatment 0.467513 blood -forming cells 0.4491 acute myeloblastic leukemia 0.44585 acute myelogenous leukemia 0.445245 chemotherapy 0.473847 PDQ cancer information 0.503817 white blood cells 0.675945 clinical trials 0.938073 mature blood cells 0.50039 cancer information summary 0.459101 clinical trial 0.615294 stem cells 0.519631 stem cell transplant 0.480735 acute granulocytic leukemia 0.446114 Myeloid Leukemia Treatment 0.448761 blood cells 0.735668 radiation therapy 0.468603 treatment 0.673705 myeloid stem cell 0.438755 stored stem cells 0.437216 immature blood cells 0.448693 arsenic trioxide 0.473356	cancer cells 0.602593 specific cancer cells 0.456728 recurrent adult aml 0.474546 untreated adult aml 0.465491 acute myeloid leukemia 0.930922 stem cell 0.533281 treatment clinical trials 0.44329 blood stem cells 0.488116 National Cancer Institute 0.460343 spinal cord 0.512703 normal cells 0.467456 myeloid stem cells 0.482174 new treatment 0.480473 white blood cell 0.463646 combination chemotherapy 0.472241 bone marrow 0.747056 cells 0.827248 acute promyelocytic leukemia 0.5928 cancer clinical trials 0.452604 acute nonlymphocytic leukemia 0.445812 acute lymphoblastic leukemia 0.434651 acute leukemia 0.43925 cancer 0.808047 standard treatment 0.467846	CLICK HERE
1849	National Cancer Institute	Html	es	Tratamiento del cáncer de próstata (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de próstata.	Compton CC 0.32822 preoperative nomogram 0.351745 outcome after 0.326979 progression after psa 0.331315 Albertsen PC 0.319652 prostate specific 0.36016 clinically localized 0.351298 Kabalin JN 0.319448 American Cancer Society 0.354812 Radical prostatectomy versus 0.362604 Eastham JA 0.338512 versus watchful waiting 0.321163 following radical prostatectomy 0.340792 PSA anormal 0.32618 7th ed 0.328183 Radiat Oncol Biol 0.401027 Estados Unidos 0.34545 Natl Cancer Inst 0.962766 cancer staging 0.41957 men with 0.323828 Stamey TA 0.333393 Radical prostatectomy treated 0.32026 Union Against Cancer 0.327902 versus gleason 0.324714 prostate biopsy 0.325976	with psa testing 0.327026 ecografía transrectal 0.331137 prostate with radiotherapy 0.319235 Cancer Facts 0.330577 gammagrafía ósea 0.32132 radical prostatectomy 0.783813 after radical prostatectomy 0.482799 Cancer Staging Manual 0.40851 recurrence after 0.340439 New York 0.323092 Clin Oncol 0.387513 predict pathological stage 0.323561 Oncol Biol Phys 0.404255 Oncology Consensus Panel 0.323099 Kattan MW 0.336259 systematic review 0.320343 with clinically localized 0.323887 Byrd DR 0.326227 American Joint Committee 0.318729 Partin AW 0.341859 transrectal ultrasound guided 0.325554 AJCC Cancer Staging 0.413497 Edge SB 0.328269 PSA following 0.325762	CLICK HERE
1939	National Cancer Institute	Html	es	Adaptación al cáncer: ansiedad y sufrimiento (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las difíciles respuestas emocionales que se presentan en muchos de los pacientes con cáncer. Este sumario se enfoca en asuntos de la adaptación normal, alteración psicosocial y trastornos de adaptación.	La espiritualidad 0.829227 siguientes aspectos 0.951689 intensa ansiedad 0.886965 siguientes tipos 0.835996 largo plazo 0.911949 ¿Qué efectos 0.840354 siguientes períodos 0.85698 siguientes síntomas 0.824791 siguientes riesgos 0.776419 Visuals Online 0.784027 Physician Data 0.774429 siguientes problemas 0.817253	siguientes factores 0.894404 Mucha transpiración 0.807275 resultados correctos 0.846693 libre uso 0.789 siguientes situaciones 0.941031 Data Query 0.774207 siguientes características 0.904197 Cancer Institute 0.786402 página manejo 0.784108 suficiente dinero 0.80221 siguientes sumarios 0.945414 usa compulsiones 0.805006	CLICK HERE
1953	National Cancer Institute	Html	es	Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de los problemas de salud que continúan o aparecen después de terminar un tratamiento de cáncer.	válvulas cardíacas 0.300344 digestivasLos efectos tardíos 0.301994 siguientes procedimientos 0.300445 células madre 0.31868 suficiente saliva 0.300202 adultos jóvenes 0.300215 tumor tipo 0.3006 leucemia linfocítica aguda 0.300977 leucemia linfoblástica aguda 0.303718 diabetes mellitus 0.300401 rayos x 0.300187 largo plazo 0.301433 alta densidad 0.300367 debilidad súbitos 0.300398 efectos tardíos 0.995697 luz solar 0.30049 tumores benignos 0.300573	siguientes maneras 0.300324 hormonas tiroideas 0.300415 antecedentes familiares 0.302575 revestimiento protector 0.300332 hepatitis b 0.300262 siguientes factores 0.300516 radiación uv 0.300991 topoisomerasa ii 0.300497 suficiente insulina 0.300239 cuerpo elabora insulina 0.300315 Radiografía panorámica 0.300213 leucemia mieloide aguda 0.302575 mandíbulasLos problemas 0.300385 cáncer infantil meses 0.303991 biliaresLos efectos tardíos 0.30194 Mayor tiempo 0.300312 siguientes pruebas 0.300654	CLICK HERE
2013	National Cancer Institute	Html	es	Aspectos generales de los exámenes de detección del cáncer (PDQ®)–Versión para pacientes	Información sobre la medición de la eficacia de los exámenes de detección del cáncer y la evaluación de la solidez de las pruebas obtenidas en estudios de investigación de detección del cáncer.	suficiente información 0.640426 riesgos.Algunos exámenes 0.948845 posibles factores 0.658466 End Results 0.782283 siguientes aspectos 0.657281 cabo ensayos 0.656668 ¿Los exámenes 0.83489 siguientes tipos 0.726625 efecto secundario adverso 0.681584 cuánto tiempo 0.658052 grupo pacientes 0.645515 información ayuda 0.635388 National Cancer Institute 0.643177	siguientes riesgos 0.629124 Instituto Nacional 0.984309 antecedentes familiares 0.663533 suficientes pruebas 0.65243 Physician Data Query 0.768953 Estados Unidos 0.927922 menor tiempo 0.639093 única razón 0.651582 posibles beneficios 0.675509 determinada enfermedad 0.640319 cuáles pruebas 0.82218 términos riesgo 0.746808 PDQ Aspectos 0.65214	CLICK HERE
3675	National Cancer Institute	Html	en	Data Submission Under the Genomic Data Sharing (GDS) Policy	Information for intramural, extramural, and non-NIH funded investigators looking to submit study data under the Genomic Data Sharing (GDS) Policy.	data instruments 0.389578 Different submission requirements 0.358856 Different data types 0.458311 data 0.914172 N/A Arrays 0.352863 Institutional Certification 0.390929 data use limitations 0.365334 phenotype data 0.455331 DNA sequence data 0.507348 clinical information 0.351464 N/A .BAM Arrays 0.717463 common data elements 0.45555 NCI intramural research 0.372571 RNAseq data 0.381683 submission process 0.341088 SNP array data 0.440533 Data reuse 0.406127 genomic data 0.788599 genomic program administrator 0.366093 controlled-access genomic data 0.507551 Raw data 0.388186 bisulfite sequencing data 0.488737 data sharing plan 0.431561 scientific review 0.378953	basis N/A .TXT 0.57172 GWAS data 0.384745 data standards 0.487591 published table 0.34424 human genomic data 0.471234 additional research questions 0.363874 data processing 0.449487 GDS policy-covered research 0.360223 human sample data 0.554048 GDS website 0.358009 DNA methylation data 0.435253 NIH data repositories 0.466908 minimizes potential errors 0.345345 data generation 0.367981 Developing Data Sharing 0.429887 exposure data 0.441991 well-documented data standards 0.480779 genomic data—such 0.394593 data submission 0.621641 data release 0.391289 NIH National Center 0.357378 genomic data submissions 0.597871 N/A .BAM NGS 0.52976	CLICK HERE
15480	National Cancer Institute	Html	en	Grantees or Grant Applicants Submitting Data	In order to be compliant with the Genomic Data Sharing (GDS) Policy, extramural investigators should use the following to guide their steps through the grant life-cycle process.	annual Progress Report 0.62504 data 0.849889 Institutional Certification 0.882661 similar manner 0.478201 accession number 0.48592 section 0.333306 PO/PD 0.491096 Assignment 0.33161 approved DSP 0.538409 extramural investigators 0.782153 1. Plan Project 0.689974 Basic Study Information 0.674507 grant funding 0.568662 confirmation 0.333875 steps 0.331094 ARA 0.342301 submission portal 0.610861 plans 0.336284 grant application 0.941037 receipt 0.33802 GDS policy 0.525866 Upload Data 0.545134 dbGaP staff 0.485771 data certification process 0.735794 program officer/program director 0.674634	grants process 0.480049 grant life-cycle process 0.816123 Basic Information form 0.63633 dbGaP Study Release 0.648367 DSPs 0.34954 initiation 0.332734 pre-award process 0.509608 submission process 0.502601 required fields 0.479311 expectations 0.381962 place 0.332574 3. 0.332387 cleaning 0.332176 data submission formats 0.780089 study submission information 0.687432 Resource Sharing Plan 0.663305 QA/QC Data Submission 0.730259 Information form 0.651102 Submit Just-in-Time Materials 0.722172 Data Generation Completed 0.715899 GPA 0.642745 quality assurance check 0.641113 Write Grant Application 0.78666 data upload 0.531576	CLICK HERE
16861	National Cancer Institute	Html	es	Terapia Gerson (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la terapia Gerson como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	múltiples detalles 0.301338 Centro Nacional 0.302469 New Hampshire Avenue 0.301732 Drug Administration 0.301078 NCI Best Case 0.303308 Max B 0.30156 datos bibliográficos pubmed 0.30187 cuerpo suficientes vitaminas 0.303678 Vitaminas A 0.301419 siguientes preguntas 0.30102 National Cancer Institute 0.302137 siguientes riesgos 0.301292 vitamina b12 0.301563 alto contenido 0.301449 Instituto Nacional 0.314894 Gerson Research Organization 0.308778 Salud Complementaria 0.303978 Visuals Online 0.301269	complementarias revisa 0.301833 PDQ Terapia Gerson 0.311186 Physician Data Query 0.307427 comidas vegetarianas 0.301548 coenzima q10 0.304748 Estados Unidos 0.316664 enzimas pancreáticas 0.305305 libre uso 0.301348 página manejo 0.301179 ¿El tratamiento 0.302348 suficiente potasio 0.301916 ¿Los beneficios 0.301092 juntos cam 0.301043 numerosos detalles 0.301552 Series Program 0.301073 terapia gerson 0.988974 medicina complementaria 0.349955	CLICK HERE